XEOMIN (incobotulinumtoxinA) Patient Assistance Program
Don’t let the high cost of brand botulinum toxin therapy disrupt your treatment. We help eligible patients access Xeomin (incobotulinumtoxinA) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Xeomin (incobotulinumtoxinA) is FDA-approved for chronic sialorrhea (drooling) in adults and pediatric patients (≥2 years), upper limb spasticity in adults and pediatric patients (≥2 years), cervical dystonia in adults, blepharospasm in adults, and improvement of moderate-to-severe glabellar lines (cosmetic). Xeomin is a purified neurotoxin type A formulation with no accessory proteins — potentially with lower immunogenicity than other botulinum toxins.
- Without assistance, Xeomin costs commonly run approximately $400–$700 per 100-unit vial for therapeutic indications (cosmetic dosing varies and is typically not covered by PAP).
- Through AffordMyPrescriptions, qualifying patients can access Xeomin for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic or biosimilar of Xeomin in the U.S. as of 2026. Other type A botulinum toxins include onabotulinumtoxinA (Botox) — the original; abobotulinumtoxinA (Dysport); prabotulinumtoxinA (Jeuveau, cosmetic only); daxibotulinumtoxinA (Daxxify). Type B option: rimabotulinumtoxinB (Myobloc). Units are NOT interchangeable between products.
What Is Xeomin Prescription Assistance Program?
The Xeomin Prescription Assistance Program is a manufacturer-sponsored initiative that provides Xeomin at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for therapeutic Xeomin indications in patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, neurology/PM&R/ophthalmology coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing injection coordination and re-certification.
Pharmacy Price Comparison
- Without assistance, Xeomin costs roughly $400–$700 per 100-unit vial. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680/vial | Save ~$610/vial |
| CVS Pharmacy | ~$700/vial | Save ~$630/vial |
| Walmart | ~$450/vial | Save ~$380/vial |
| Costco | ~$430/vial | Save ~$360/vial |
Specialty Pharmacy | ~$550/vial | Save ~$480/vial |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Xeomin Prescription Program?
The Patient Assistance Program is free to apply for and provides Xeomin at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Xeomin:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $400–$700/vial per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Xeomin assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Xeomin Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Xeomin:
Xeomin (incobotulinumtoxinA) is a purified type A botulinum neurotoxin used to treat several neurologic and dermatologic conditions involving abnormal muscle contractions or excessive secretion. Its purified formulation (no accessory complexing proteins) may have lower immunogenicity than Botox or Dysport — relevant for patients on long-term botulinum toxin therapy.
How Xeomin Works:
Xeomin is a purified botulinum toxin that works at neuromuscular junctions or autonomic synapses by entering presynaptic nerve terminals and cleaving SNAP-25, a protein essential for acetylcholine release. Without this protein, acetylcholine cannot enter the synapse, which causes targeted and reversible chemodenervation that reduces involuntary muscle contractions or salivary gland secretions. The effects typically develop within days to two weeks and last around three months until new nerve terminals sprout to restore neurotransmitter release. Because its formulation is highly purified and contains no accessory proteins, it may reduce the risk of forming neutralizing antibodies that cause treatment nonresponse over time.
Form and use:
This medication is administered exclusively via intramuscular or intraglandular injections by trained healthcare providers, with highly individualized doses based on the patient and target area. Standard total doses range from 25 to 50 units per eye for blepharospasm, 100 units for chronic sialorrhea, up to 240 units for cervical dystonia, and up to 400 units for upper limb spasticity. The therapeutic effects generally last between three to four months, requiring repeat injections to be scheduled at least 12 weeks apart.
Generic availability:
As of 2026, there are no generic or biosimilar versions of Xeomin available in the United States. Other type A botulinum toxin alternatives include Botox, Dysport, Daxxify, and Jeuveau, while Myobloc is available as a type B alternative for patients who have developed a resistance to Botox. It is critical to note that the potency units across these different products are not interchangeable, and their conversion ratios vary by the specific indication being treated.
Warnings:
Xeomin carries a prominent Boxed Warning regarding the potential distant spread of the toxin effect, which can cause serious and life-threatening weakness, swallowing difficulties, or breathing problems. These respiratory and swallowing complications are especially risky for patients treated for cervical dystonia or sialorrhea, as well as those with pre-existing neuromuscular disorders like myasthenia gravis. Additional warnings include rare allergic reactions, eye-related adverse effects following periocular injections, and general generalized weakness.
FAQ (Frequently Asked Questions)
How Much Does Xeomin Cost Without Insurance?
Xeomin costs approximately $400–$700 per 100-unit vial. Most patients require multiple vials per session and 3–4 sessions per year. Annual costs commonly $5,000–$15,000+ for chronic spasticity or dystonia. Through AffordMyPrescriptions, qualifying patients receive Xeomin at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Xeomin Different From Botox?
Both are type A botulinum toxins. Botox (onabotulinumtoxinA) is the original, most widely studied, with extensive long-term data. Xeomin (incobotulinumtoxinA) is ‘naked’ toxin without the accessory proteins that surround botulinum toxin in Botox/Dysport — potentially with lower risk of neutralizing antibody formation that can cause secondary nonresponse to long-term therapy. Units are NOT interchangeable between products. Both are effective; choice often depends on prior response, antibody status, insurance coverage, and provider familiarity.
What If I've Developed Resistance To Botox?
About 1–5% of patients on long-term botulinum toxin therapy develop neutralizing antibodies and become ‘secondary non-responders’ — getting less benefit from each injection. Switching to Xeomin (incobotulinumtoxinA) is one strategy because its purified formulation (no accessory proteins) may have lower immunogenicity. Some patients regain response on Xeomin after failing Botox. Type B toxin (Myobloc/rimabotulinumtoxinB) is another option since it targets different presynaptic proteins (no cross-reactivity with type A antibodies).
How Long Until I See Effects?
Effects develop gradually over 1–2 weeks after injection. Peak effect is typically at 2–4 weeks. Duration is typically 3–4 months — at which point symptoms gradually return and repeat injections are scheduled. Don’t expect immediate response after injection; allow 2 weeks before assessing full effect.
What Side Effects Should I Watch For?
Most common: injection site pain/bruising, transient weakness of injected muscles. Important to watch for: difficulty swallowing (especially after cervical dystonia or sialorrhea injections — can occasionally be severe; tell provider if persistent), breathing difficulty (rare), generalized weakness, blurred or double vision (with periocular injection), dry eyes/tearing changes, drooling changes. Tell your provider immediately about breathing or swallowing problems.
Will My Insurance Cover Xeomin?
Most insurance plans cover Xeomin for FDA-approved therapeutic indications (sialorrhea, spasticity, cervical dystonia, blepharospasm) with prior authorization. Insurance typically does NOT cover Xeomin for cosmetic indications (glabellar lines). Documentation of medical necessity (failure or intolerance of less expensive treatments where applicable, severity of symptoms) is usually required. Our team helps with prior authorization.
What If My Application Is Denied?
If denied, we explore alternatives — switching to Botox or Dysport with their own PAPs, the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Dystonia Medical Research Foundation, National Organization for Rare Disorders, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Xeomin, our team may be able to help you access assistance programs designed to make brand botulinum toxin therapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.